Endonovo Therapeutics, Inc. (ENDV)
0.0000
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Endonovo Therapeutics EPS Diluted (Quarterly) : -0.0003 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0003 |
| March 31, 2026 | -0.0003 |
| December 31, 2025 | -0.0003 |
| September 30, 2025 | -0.0003 |
| June 30, 2025 | -0.0005 |
| March 31, 2025 | -0.0005 |
| December 31, 2024 | -0.0012 |
| September 30, 2024 | -0.0018 |
| June 30, 2024 | -0.0018 |
| March 31, 2024 | -0.0011 |
| December 31, 2023 | -0.005 |
| September 30, 2023 | -0.0026 |
| June 30, 2023 | -0.0008 |
| March 31, 2023 | 0.0042 |
| December 31, 2022 | -0.0606 |
| September 30, 2022 | -0.0039 |
| June 30, 2022 | -0.0188 |
| March 31, 2022 | -0.0305 |
| December 31, 2021 | 0.0322 |
| September 30, 2021 | -0.023 |
| June 30, 2021 | -0.0222 |
| March 31, 2021 | -0.0645 |
| December 31, 2020 | -0.0828 |
| September 30, 2020 | -0.0662 |
| June 30, 2020 | -0.1662 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1423 |
| December 31, 2019 | -5.834 |
| September 30, 2019 | -1.81 |
| June 30, 2019 | -13.57 |
| March 31, 2019 | -4.99 |
| December 31, 2018 | 3.21 |
| September 30, 2018 | -16.11 |
| June 30, 2018 | -3.59 |
| March 31, 2018 | -1.89 |
| December 31, 2017 | 5.58 |
| September 30, 2017 | -30.00 |
| June 30, 2017 | 10.00 |
| March 31, 2017 | -50.00 |
| December 31, 2016 | -10.00 |
| September 30, 2016 | -20.00 |
| June 30, 2016 | -10.00 |
| March 31, 2016 | -10.00 |
| December 31, 2015 | -43.20 |
| September 30, 2015 | -12.56 |
| June 30, 2015 | -10.00 |
| March 31, 2015 | -10.00 |
| December 31, 2014 | -2.74 |
| September 30, 2014 | 2.09 |
| June 30, 2014 | -260.00 |
| March 31, 2014 | -1000.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 0.2412 |
| Accuray, Inc. | -0.0154 |
| Micron Solutions, Inc. | -- |
| Perspective Therapeutics, Inc. | -0.222 |
| Orthofix Medical, Inc. | -0.3862 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.5884M |
| Total Expenses (Quarterly) | 0.5884M |
| Enterprise Value | 7.104M |
| Earnings Yield | -2.40K% |
| Normalized Earnings Yield | -2400.00 |